Rare Diseases
Tobramycin PSK
Registration certificate:
INN:
Tobramycin
Release form:
Solution for inhalation
Therapeutic Area:
Rare Diseases
Pharmacotherapeutic Group:
Antibacterial agents for systemic use, Aminoglycosides, Other aminoglycosides
Conditions for dispensing:
On prescription
Packaging:

Indications:

  • Tobramycin PSC is indicated for the treatment of lung infections caused by Pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis.

  • Pseudomonas aeruginosa frequently causes lung infections in patients with cystic fibrosis, which can recur multiple times throughout their lives. If left untreated, these infections can cause additional lung damage and exacerbate breathing problems.

Tobramycin PSK is in the Essential Medicines List.

Quality control
at all stages of production